Maurice Zauderer's most recent trade in Vaccinex Inc was a trade of 46,153 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on Nov. 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.25 per share. | 14 Nov 2024 | 46,153 | 297,941 (1%) | 0% | 3.2 | 149,997 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 170,475 | 170,475 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.64 per share. | 18 Sep 2024 | 38,610 | 176,748 (1%) | 0% | 5.6 | 217,606 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 38,610 | 0 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.64 per share. | 18 Sep 2024 | 35,715 | 251,788 (1%) | 0% | 5.6 | 201,290 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 35,715 | 0 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.64 per share. | 18 Sep 2024 | 29,557 | 206,305 (1%) | 0% | 5.6 | 166,583 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 29,557 | 0 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.64 per share. | 18 Sep 2024 | 9,768 | 216,073 (1%) | 0% | 5.6 | 55,052 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 9,768 | 0 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 38,610 | 38,610 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.77 per share. | 28 Mar 2024 | 38,610 | 138,138 (0%) | 0% | 7.8 | 300,000 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 1,877 | 1,877 | - | - | Stock Option (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2024 | 1,877 | 1,877 | - | - | Stock Option (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 08 Feb 2024 | 413,793 | 1,393,392 (8%) | 2% | 0.7 | 300,000 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 413,793 | 413,793 | - | - | Warrant (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.41 per share. | 31 Mar 2023 | 731,707 | 5,142,691 (31%) | 4% | 0.4 | 300,000 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | 06 Dec 2022 | 3,988 | 181,736 (1%) | 0% | 0 | Common Stock | ||
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.53 per share. | 23 Nov 2022 | 1,511,430 | 4,410,984 (26%) | 9% | 0.5 | 800,000 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 27 Jan 2022 | 1,801,801 | 2,899,554 (17%) | 11% | 1.1 | 1,999,999 | Common Stock |
Vaccinex Inc | Maurice Zauderer | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) |